Logo image of HIL

HILL INTERNATIONAL INC (HIL) Stock Fundamental Analysis

NYSE:HIL - New York Stock Exchange, Inc. - US4314661012 - Common Stock - Currency: USD

3.4  +0.02 (+0.59%)

Fundamental Rating

2

Overall HIL gets a fundamental rating of 2 out of 10. We evaluated HIL against 82 industry peers in the Professional Services industry. Both the profitability and financial health of HIL have multiple concerns. HIL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HIL had positive earnings in the past year.
In the past year HIL has reported a negative cash flow from operations.
HIL Yearly Net Income VS EBIT VS OCF VS FCFHIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M

1.2 Ratios

HIL has negative profitability rations, so we won't be analyzing them here.
HIL's Return On Invested Capital of 6.55% is in line compared to the rest of the industry. HIL outperforms 43.94% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HIL is below the industry average of 13.36%.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.81%
ROIC(5y)N/A
HIL Yearly ROA, ROE, ROICHIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20 -40

1.3 Margins

HIL has a worse Operating Margin (3.21%) than 69.70% of its industry peers.
The Profit Margin and Gross Margin are not available for HIL so they could not be analyzed.
Industry RankSector Rank
OM 3.21%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIL Yearly Profit, Operating, Gross MarginsHIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HIL is still creating some value.
Compared to 1 year ago, HIL has more shares outstanding
Compared to 1 year ago, HIL has a worse debt to assets ratio.
HIL Yearly Shares OutstandingHIL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
HIL Yearly Total Debt VS Total AssetsHIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.12 indicates that HIL is not a great score, but indicates only limited risk for bankruptcy at the moment.
HIL has a Altman-Z score of 2.12. This is in the lower half of the industry: HIL underperforms 65.15% of its industry peers.
HIL has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
HIL has a Debt to Equity ratio (0.30) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.12
ROIC/WACC0.78
WACC8.37%
HIL Yearly LT Debt VS Equity VS FCFHIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.59 indicates that HIL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.59, HIL is in line with its industry, outperforming 54.55% of the companies in the same industry.
A Quick Ratio of 1.59 indicates that HIL should not have too much problems paying its short term obligations.
HIL has a Quick ratio of 1.59. This is comparable to the rest of the industry: HIL outperforms 56.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
HIL Yearly Current Assets VS Current LiabilitesHIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1729382256910270464.00% over the past year.
Looking at the last year, HIL shows a quite strong growth in Revenue. The Revenue has grown by 8.58% in the last year.
HIL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.06% yearly.
EPS 1Y (TTM)1729382256910270500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
Revenue 1Y (TTM)8.58%
Revenue growth 3Y-4.16%
Revenue growth 5Y-6.06%
Sales Q2Q%13.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HIL Yearly Revenue VS EstimatesHIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M
HIL Yearly EPS VS EstimatesHIL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 0 0.1 0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 113.33, the valuation of HIL can be described as expensive.
Based on the Price/Earnings ratio, HIL is valued a bit more expensive than the industry average as 77.27% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 24.95, HIL is valued quite expensively.
Industry RankSector Rank
PE 113.33
Fwd PE N/A
HIL Price Earnings VS Forward Price EarningsHIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIL.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.95
HIL Per share dataHIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HILL INTERNATIONAL INC

NYSE:HIL (12/23/2022, 8:04:00 PM)

3.4

+0.02 (+0.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)03-29 2023-03-29
Inst Owners5.84%
Inst Owner Change0%
Ins Owners16%
Ins Owner Change0%
Market Cap194.10M
Analysts45
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 113.33
Fwd PE N/A
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B 2
P/tB 3.58
EV/EBITDA 14.95
EPS(TTM)0.03
EY0.88%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS7.18
BVpS1.7
TBVpS0.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 6.55%
ROICexc 7.66%
ROICexgc 11.21%
OM 3.21%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.81%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.92
Cap/Depr 83.24%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 2.12
F-Score2
WACC8.37%
ROIC/WACC0.78
Cap/Depr(3y)78.64%
Cap/Depr(5y)61.53%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1729382256910270500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.58%
Revenue growth 3Y-4.16%
Revenue growth 5Y-6.06%
Sales Q2Q%13.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-195.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-163.79%
OCF growth 3YN/A
OCF growth 5YN/A